Chan ATC - Search Results

1

Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.

Bell AI, Groves K, Kelly GL, Croom-Carter D, Hui E, Chan ATC, Rickinson AB. Bell AI, et al. Among authors: chan atc. J Gen Virol. 2006 Oct;87(Pt 10):2885-2890. doi: 10.1099/vir.0.81906-0. J Gen Virol. 2006. PMID: 16963746

2

Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.

Whitney BM, Chan AT, Rickinson AB, Lee SP, Lin CK, Johnson PJ. Whitney BM, et al. J Med Virol. 2002 Jul;67(3):359-63. doi: 10.1002/jmv.10073. J Med Virol. 2002. PMID: 12116028

3

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.

Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL. Hui EP, et al. Clin Cancer Res. 2002 Aug;8(8):2595-604. Clin Cancer Res. 2002. PMID: 12171890

4

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Chan AT, et al. J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9. doi: 10.1093/jnci/94.21.1614. J Natl Cancer Inst. 2002. PMID: 12419787

5

Nasopharyngeal cancer.

Chan AT, Teo PM, Johnson PJ. Chan AT, et al. Cancer Treat Res. 2003;114:275-93. doi: 10.1007/0-306-48060-3_11. Cancer Treat Res. 2003. PMID: 12619546 Review. No abstract available.

6

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM. Chan KC, et al. Cancer Res. 2003 May 1;63(9):2028-32. Cancer Res. 2003. PMID: 12727814

7

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Leung SF, et al. Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347 Free article.

8

Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.

To EW, Chan KC, Leung SF, Chan LY, To KF, Chan AT, Johnson PJ, Lo YM. To EW, et al. Clin Cancer Res. 2003 Aug 15;9(9):3254-9. Clin Cancer Res. 2003. PMID: 12960110

9

Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.

Leung SF, Lo YM, Chan AT, To KF, To E, Chan LY, Zee B, Huang DP, Johnson PJ. Leung SF, et al. Clin Cancer Res. 2003 Aug 15;9(9):3431-4. Clin Cancer Res. 2003. PMID: 12960133

10

A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.

Hui EP, Poon TC, Teo PM, Mo F, Zee B, Leung SF, Ho S, Mok TS, Kwan WH, Johnson PJ, Chan AT. Hui EP, et al. Radiother Oncol. 2003 Oct;69(1):53-62. doi: 10.1016/s0167-8140(03)00248-2. Radiother Oncol. 2003. PMID: 14597357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters